CAS RN: 289721-03-5
2-Oxazolamine,4,5-dihydro-4-(1-methylethyl)-,(4S)-(9CI)
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 289721-03-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>95%
0
Out of Stock
Beijing
Inquiry
289721-03-5 / (4S)-4-propan-2-yl-4,5-dihydro-1,3-oxazol-2-amine
Standard CAS: 289721-03-5
Multi CAS: No
Basic Information
copy
CAS
289721-03-5 copy
Multi CAS
No copy
Molecular Formula
C6H12N2O copy
Molecular Weight
128.170000 copy
Exact Mass
128.094963 copy
InChI
InChI=1S/C6H12N2O/c1-4(2)5-3-9-6(7)8-5/h4-5H,3H2,1-2H3,(H2,7,8)/t5-/m1/s1 copy
InChIKey
RKTWYSWYCPYDJG-RXMQYKEDSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
0.83 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
36.2 copy
TPSA
47.61 copy
LogP / Solubility
WLOGP
0.36 copy
MLOGP
0.3 copy
XLogP3
0.6 copy
Consensus LogP
0.42 copy
Log S (ESOL)
-0.79 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.87 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.91 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.25 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy